Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 3Unknown 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Head & Neck 1Genitourinary 1

Conditions

Stomach Neoplasms 1Neoplastic Cells, Circulating 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 288Capecitabine 218Fluorouracil 212Irinotecan 145Leucovorin 139Gemcitabine 124S 1 (combination) 110apatinib 109Cisplatin 102Drug Therapy 98Bevacizumab 98Radiotherapy 97Paclitaxel 97camrelizumab 89sintilimab 79Cetuximab 75lenvatinib 62Neoadjuvant Therapy 61tislelizumab 55Surgical Procedures, Operative 54Sorafenib 53Folfox protocol 53toripalimab 52Docetaxel 52130-nm albumin-bound paclitaxel 47Laparoscopy 41HMPL-013 40XELOX 39Radiosurgery 36Albumin-Bound Paclitaxel 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Circulating Tumor DNA × Gastrointestinal × Clear all
NCT05635630 2022-12-02

Predictive Value of ctDNA for NED Status in mCRC and Its Utility in Guiding Therapeutic Intervention

Fudan University

Phase NA Unknown
110 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03957564 2020-01-22

Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric Cancer

Affiliated Hospital of Qinghai University

Phase 2 Unknown
40 enrolled
Gastrointestinal

Neoplastic Cells, Circulating, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡